NLRP3 and metabolic dysfunction-associated steatotic liver disease: found that NLRP3, procaspase-1, IL-1β, and IL-18 mRNA levels were significantly increased in the livers of NAFLD patients compared to healthy controls (Mitsuyoshi et al., 2017).